Gen-Probe’s Analytical Labs Pass FDA Inspection

Gen-Probe’s Tepnel Pharma Services successfully passed an FDA GMP inspection of its analytical labs in Livingston, Scotland, without any Form 483 citations. This is the second FDA audit since Tepnel relocated to its current facilities in 2008. The site is also certified by the MHRA for GMP, GLP and GCP compliance.

Carl Hull, chief executive officer of Gen-Probe, said, “This accomplishment reflects our long-standing corporate commitment to quality and regulatory compliance.”

Tepnel provides pharmaceutical testing and research in the areas of batch release and stability testing, clinical trials support including bioanalysis and pharmacogenomics, and immunology.